Pubrica


The Lancet journals are both a destination for publication and a platform to advance the global impact of research. The Lancet Group cares that your work is highly visible to a global network of researchers, clinicians, industry professionals, policy makers, media outlets, patients, and the wider public, and we work with you and your affiliated institutions to maximise the impact of your research on the world. As part of this commitment, Lancet Infectious Diseases publication standards support authors seeking strong visibility in the infectious diseases journal submission landscape, and high-quality manuscript editing for Lancet journals ensures that research is communicated clearly and effectively.

Lancet journals have an extensive global reach with more than 41·5 million annual visits and 155·2 million downloaded articles across TheLancet.com and ScienceDirect, supported further by professional manuscript editing services designed to enhance clinical research publication quality and impact.

The Lancet Infectious Diseases

The Lancet journals are both a destination for publication and a platform to advance the global impact of research. The Lancet Group cares that your work is highly visible to a global network of researchers, clinicians, industry professionals, policy makers, media outlets, patients, and the wider public, and we work with you and your affiliated institutions to maximise the impact of your research on the world. As part of this commitment, Lancet Infectious Diseases publication standards support authors seeking strong visibility in the infectious diseases journal submission landscape, and high-quality manuscript editing for Lancet journals ensures that research is communicated clearly and effectively.

Lancet journals have an extensive global reach with more than 41·5 million annual visits and 155·2 million downloaded articles across TheLancet.com and ScienceDirect, supported further by professional manuscript editing services designed to enhance clinical research publication quality and impact.

Aim and Scope

The world-leading infectious diseases journal dedicated to research and review, We publish original research that advocates change in or illuminates infectious disease clinical practice and informative reviews on any topic connected with infectious diseases and human health. Our preference is to publish articles likely to influence clinical practice or thinking. Topics include but are not limited to anti-infective therapy and immunisation; bacterial, viral, fungal, and parasitic infections; emerging infectious diseases; HIV/AIDS, malaria, and tuberculosis and mycobacterial infections; infection control; infectious diseases epidemiology; neglected tropical diseases and travel medicine.

JOURNAL TEMPLATE - COVER IMAGE

The Lancet Infectious Diseases

Impact Factor

Impact Factor

31.0

SJR (SCImago Journal Rank)

SJR (SCImago Journal Rank)

NA

CiteScore

CiteScore

42.6

Frequency

Frequency

Monthly

Publisher

Elsevier

Acceptance Rate

5-7%

Key Highlights

5-Year Impact Factor

26.9

H-Index

291

Indexing

PubMed/MEDLINE, Web of Science, Scopus, Embase, CINAHL.

Initial Editorial Decision

3-5 Days,

First Post-Review Decision

1.1 Month

Submission to Acceptance

NA

Acceptance to Publication

Around 21 weeks

Publication Type

The Lancet Infectious Diseases publishes original research, reviews, opinion pieces, and news, covering a wide range of infectious disease topics

Open Access Model

Open Access Model, hybrid Journal

Article Processing Charges (APC)

$7,280 USD (excluding taxes)

Main text

Maximum word count of 3,000–4,500 words

Abstract

Abstract has a limit of 300 words

References

30–50 references

Tables/Figures

No word count

This will close in 0 seconds